FDA 'Open' to 510(k) Proposals
Public Citizen's health research group for years has asserted that the FDA's procedures for clearing medical devices under the 510(k) process are flawed and fail to adequately protect public health."
Challoner rebuffed suggestions that existing regulations already thwart medical device innovation and that the IOM recommendations will only make the situation more difficult. "There is no way of assessing, based on a review of available evidence, whether current regulations are having either a positive or a negative effect on innovation. He suggested that the FDA commission to review the issue.
For its part, the FDA said it already has underway efforts to incorporate some of the IOM findings to strengthen the 510 (k) process, including clarifying when manufacturer changes to a 510(k)-cleared device already on the market warrant a new 510(k) submission.
Margaret Dick Tocknell is a reporter/editor with HealthLeaders Media.
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- Proton Beam Therapy Poised for Growth in US
- mHealth Tackles Readmissions
- 4 Crucial Tactics for Reining in Healthcare Cost
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- CNO Leads $1M Charge for New Scrubs, Uniforms
- How, and Why, to Recruit Male Nurses
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013